U.S. health regulators are defending their handling of Moderna’s mRNA flu vaccine application after initially declining to review it, while signaling the decision may not be final.
Meloni: “Approviamo la manovra, poi pronti al voto”. Ma palazzo Chigi teme la Consulta
Ottobre 28, 2026
Read More [#item_full_content]
